Condition
Advanced Solid Tumors Harboring RAS Mutations or Amplifications clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Advanced Solid Tumors Harboring RAS Mutations or Amplifications clinical trials that are recruiting, in China. By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
HRS-2329 for advanced solid tumors with RAS mutations or amplifications
This trial will test the oral drug HRS-2329 in adults with advanced solid tumors that have RAS mutations or amplifications who have not responded to standard treatments.
-
HRS-7172 for advanced solid tumors with RAS mutations or amplifications
This study will try an experimental oral drug called HRS-7172 in adults with advanced solid tumors that have RAS mutations or amplifications to see if it is safe and how the body handles it.
Quick answers
How many Advanced Solid Tumors Harboring RAS Mutations or Amplifications clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.